Table 2.
Perioperative and postoperative data
| Ambulatory success (n=45) | Ambulatory failure (n=7) | Total (n=52) | p | |
|---|---|---|---|---|
|
| ||||
| ASA score ≥ 3, n (%) | 10 (22.2) | 0 (0) | 10 (19.2) | 0.322 |
|
| ||||
| Anesthetic type, n (%) | 0.613 | |||
| Spinal | 17 (37.8) | 4 (57.1) | 21 (40.4) | |
| Laryngeal mask airway | 14 (31.1) | 2 (28.6) | 16 (30.8) | |
| Intubation | 14 (31.1) | 1 (14.3) | 15 (28.8) | |
|
| ||||
| Surgery time (min) | 0.046 | |||
| Mean (SD) | 97.4 (30.4) | 126.1 (47.5) | 101.3 (34.1) | |
| Median | 90.0 | 109.0 | 91.0 | |
| Range | (56.0–202.0) | (88.0–225.0) | (53.0–225.0) | |
|
| ||||
| Delivered energy (J) | 0.604 | |||
| Mean (SD) | 93.1 (26.4) | 83.0 (10.4) | 92.2 (25.4) | |
| Median | 86.6 | 80.9 | 84.6 | |
| Range | (38.9–140.2) | (72.6–97.4) | (38.9–140.2) | |
|
| ||||
| Morcellated prostate volume (g) | 0.302 | |||
| Mean (SD) | 55.3 (22.4) | 72.1 (35.7) | 57.5 (24.9) | |
| Median | 53.0 | 72.0 | 53.5 | |
| Range | (20.0–111.5) | (31.5–127.5) | (20.0–127.5) | |
|
| ||||
| Benign pathology, n (%) | 37 (82.2) | 7 (100.0) | 44 (84.6) | 0.578 |
|
| ||||
| Hemoglobin (g/L) | 0.002 | |||
| Mean (SD) | 142.8 (12.2) | 120.5 (16.6) | 137.2 (16.3) | |
| Median | 143.0 | 126.5 | 138.5 | |
| Range | (118.0–170.0) | (92.0–136.0) | (92.0–170.0) | |
| Change from baseline (SD) | −6.9 (8.3) | −19.2 (17.4) | −10.4 (12.5) | |
|
| ||||
| Prostate-specific antigen(ng/mL) | 0.543 | |||
| Mean (SD) | 0.8 (0.8) | 1.1 (1.8) | 0.8 (0.9) | |
| Median | 0.6 | 0.5 | 0.6 | |
| Range | (0.1–2.9) | (<0.1–4.7) | (<0.1–4.7) | |
| Change from baseline (SD) | −6.3 (5.5) | −3.3 (2.1) | −5.7 (5.3) | |
|
| ||||
| Serum creatinine (micromole/L) | 0.346 | |||
| Mean (SD) | 91.3 (20.4) | 81.0 (22.5) | 89.8 (20.8) | |
| Median | 88.5 | 78.0 | 88.0 | |
| Range | (65.0–155.0) | (46.0–115.0) | (46.0–155.0) | |
| Change from baseline (SD) | 0.7 (13.3) | −4.0 (10.0) | 0.0 (12.9) | |
ASA: American Society of Anesthesiologists; SD: standard deviation.